Neurocrine Biosciences, Inc. (NBIX) Lobbying Data
NBIX lobbying summary
Neurocrine Biosciences, Inc. (NBIX) has reported $28.7M in federal lobbying spending across 129 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Medicare/Medicaid, Budget/Appropriations, Pharmacy. Lobbying firms used include Neurocrine Biosciences, Inc, Bgr Government Affairs, Tarplin, Downs & Young, LLC.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $3.5M |
| 2025 | $4.6M |
| 2024 | $4.3M |
| 2023 | $4.1M |
| 2022 | $5.1M |
| 2021 | $4.2M |
See insider trading for NBIX or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.